Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 9Rectal Neoplasms 2Carcinoma, Hepatocellular 2Urachal cancer 1Pancreatic Adenocarcinoma 1Neoplasms 1Colorectal Neoplasms 1Borderline Resectable Pancreatic Cancer 1

Interventions

Oxaliplatin 47Capecitabine 46Fluorouracil 40Leucovorin 30Radiotherapy 25Irinotecan 20Chemoradiotherapy 14Bevacizumab 14Cetuximab 12Neoadjuvant Therapy 11Folfox protocol 11Chemotherapy, Adjuvant 11XELOX 10Laparoscopy 10Drug Therapy 9Surgical Procedures, Operative 6Robotic Surgical Procedures 5Radiation 5Mastectomy, Segmental 5Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Panitumumab 4Gemcitabine 4FOLFOXIRI protocol 4durvalumab 3Simvastatin 3Magnetic Resonance Spectroscopy 3Indocyanine Green 3tislelizumab 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Rectal Neoplasms × folfirinox × Clear all
NCT05081687 2023-10-11

BRAZIL-TNT

Hospital Israelita Albert Einstein

Phase 3 Unknown
150 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT05868317 2023-05-22

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Salah Azaïz Cancer Institute

Phase 2 Unknown
70 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡